-
Diagnostics World | AI took center stage in diagnostics stories in 2023, assessing breast cancer prognoses and helping identify biomarkers. But it’s also under the microscope as researchers seek to validate “black box” AI findings. Plus: news from Illumina and a call for more diverse cystic fibrosis screening. Here’s a look at the top stories from Diagnostics World as well as thought leaders in the industry.
Jan 4, 2024
-
Diagnostics World | To kick off the New Year, we spoke with leaders and experts in the Diagnostic World community about their insights and predictions for 2024.
Jan 3, 2024
-
Diagnostics World | PerkinElmer has acquired Covaris; Revvity has launched its EONIS Q system, which can help test for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.
Dec 28, 2023